Chan Jean L, Williams Catherine J, Raciti Patricia, Blakeman Jennifer, Kelesidis Theodore, Kelesidis Iosif, Johnson Michael L, Thorner Michael O, Mantzoros Christos S
Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.
J Clin Endocrinol Metab. 2008 Jul;93(7):2819-27. doi: 10.1210/jc.2008-0056. Epub 2008 Apr 29.
States of acute and chronic energy deficit are characterized by increased GH secretion and decreased IGF-I levels.
The objective of the study was to determine whether changes in levels of leptin, a key mediator of the adaptation to starvation, regulate the GH-IGF system during energy deficit.
DESIGN, SETTING, PATIENTS, AND INTERVENTION: We studied 14 healthy normal-weight men and women during three conditions: baseline fed and 72-h fasting (to induce hypoleptinemia) with administration of placebo or recombinant methionyl human leptin (r-metHuLeptin) (to reverse the fasting associated hypoleptinemia). We also studied eight normal-weight women with exercise-induced chronic energy deficit and hypothalamic amenorrhea at baseline and during 2-3 months of r-metHuLeptin treatment.
GH pulsatility, IGF levels, IGF and GH binding protein (GHBP) levels were measured.
During short-term energy deficit, measures of GH pulsatility and disorderliness and levels of IGF binding protein (IGFBP)-1 increased, whereas leptin, insulin, IGF-I (total and free), IGFBP-4, IGFBP-6, and GHBP decreased; r-metHuLeptin administration blunted the starvation-associated decrease of IGF-I. In chronic energy deficit, total and free IGF-I, IGFBP-6, and GHBP levels were lower, compared with euleptinemic controls; r-metHuLeptin administration had no major effect on GH pulsatility after 2 wk but increased total IGF-I levels and tended to increase free IGF-I and IGFBP-3 after 1 month.
The GH/IGF system changes associated with energy deficit are largely independent of leptin deficiency. During acute energy deficit, r-metHuLeptin administration in replacement doses blunts the starvation-induced decrease of IGF-I, but during chronic energy deficit, r-metHuLeptin administration increases IGF-I and tends to increase free IGF-I and IGFBP-3.
急性和慢性能量缺乏状态的特征是生长激素(GH)分泌增加和胰岛素样生长因子-I(IGF-I)水平降低。
本研究的目的是确定瘦素(饥饿适应的关键调节因子)水平的变化是否在能量缺乏期间调节GH-IGF系统。
设计、场所、患者和干预措施:我们研究了14名健康的正常体重男性和女性,分三种情况进行:基线进食状态、72小时禁食(以诱导低瘦素血症)并给予安慰剂或重组甲硫氨酰人瘦素(r-metHuLeptin)(以逆转与禁食相关的低瘦素血症)。我们还研究了8名正常体重女性,她们在基线时以及接受r-metHuLeptin治疗的2至3个月期间存在运动诱导的慢性能量缺乏和下丘脑性闭经。
测量GH脉冲性、IGF水平、IGF和GH结合蛋白(GHBP)水平。
在短期能量缺乏期间,GH脉冲性和紊乱程度指标以及IGF结合蛋白(IGFBP)-1水平升高,而瘦素、胰岛素、IGF-I(总水平和游离水平)、IGFBP-4、IGFBP-6和GHBP降低;给予r-metHuLeptin可减弱饥饿相关的IGF-I降低。在慢性能量缺乏时,与正常瘦素水平的对照组相比,总IGF-I和游离IGF-I、IGFBP-6和GHBP水平较低;给予r-metHuLeptin在2周后对GH脉冲性无主要影响,但在1个月后可增加总IGF-I水平,并倾向于增加游离IGF-I和IGFBP-3。
与能量缺乏相关的GH/IGF系统变化在很大程度上独立于瘦素缺乏。在急性能量缺乏期间,给予替代剂量的r-metHuLeptin可减弱饥饿诱导的IGF-I降低,但在慢性能量缺乏期间,给予r-metHuLeptin可增加IGF-I,并倾向于增加游离IGF-I和IGFBP-3。